InvestorsObserver
×
News Home

Kezar Life Sciences Inc (KZR) is down -1.10% in a Week, Should You Hold?

Thursday, August 11, 2022 12:41 PM | InvestorsObserver Analysts

Mentioned in this article

Kezar Life Sciences Inc (KZR) is down -1.10% in a Week, Should You Hold?

A rating of 96 puts Kezar Life Sciences Inc (KZR) near the top of the Biotechnology industry according to InvestorsObserver. Kezar Life Sciences Inc's score of 96 means it scores higher than 96% of stocks in the industry. Kezar Life Sciences Inc also received an overall rating of 83, putting it above 83% of all stocks. Biotechnology is ranked 28 out of the 148 industries.

Overall Score - 83
KZR has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on KZR!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 83 means the stock is more attractive than 83 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Kezar Life Sciences Inc Stock Today?

Kezar Life Sciences Inc (KZR) stock has fallen -1.49% while the S&P 500 is up 0.51% as of 12:40 PM on Thursday, Aug 11. KZR is lower by -$0.15 from the previous closing price of $10.04 on volume of 359,904 shares. Over the past year the S&P 500 is down -4.85% while KZR is up 69.06%. KZR lost -$1.05 per share the over the last 12 months. Click Here to get the full Stock Report for Kezar Life Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App